Cite
Safety and effectiveness of response-guided therapy using pegylated interferon and ribavirin for chronic hepatitis C virus infection in patients on maintenance dialysis.
MLA
Goel, Amit, et al. “Safety and Effectiveness of Response-Guided Therapy Using Pegylated Interferon and Ribavirin for Chronic Hepatitis C Virus Infection in Patients on Maintenance Dialysis.” Nephrology, vol. 22, no. 9, Sept. 2017, pp. 706–11. EBSCOhost, https://doi.org/10.1111/nep.12833.
APA
Goel, A., Bhadauria, D. S., Kaul, A., Prasad, N., Gupta, A., Sharma, R. K., Rai, P., & Aggarwal, R. (2017). Safety and effectiveness of response-guided therapy using pegylated interferon and ribavirin for chronic hepatitis C virus infection in patients on maintenance dialysis. Nephrology, 22(9), 706–711. https://doi.org/10.1111/nep.12833
Chicago
Goel, Amit, Dharmendra Singh Bhadauria, Anupma Kaul, Narayan Prasad, Amit Gupta, Raj Kumar Sharma, Praveer Rai, and Rakesh Aggarwal. 2017. “Safety and Effectiveness of Response-Guided Therapy Using Pegylated Interferon and Ribavirin for Chronic Hepatitis C Virus Infection in Patients on Maintenance Dialysis.” Nephrology 22 (9): 706–11. doi:10.1111/nep.12833.